Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Bevacizumab

Australian Public Assessment Report

AusPAR

AusPAR: Bevacizumab [PDF, 725.41 KB]

AusPAR: Bevacizumab [Word, 617.27 KB]

Attachment: Product Information: Bevacizumab [PDF, 565.44 KB]

Attachment: Product Information: Bevacizumab [Word, 380.58 KB]

Attachment: Extract from the Clinical Evaluation Report: Bevacizumab [PDF, 1.05 MB]

Attachment: Extract from the Clinical Evaluation Report: Bevacizumab [Word, 1.98 MB]

Device/Product Name

Avastin

Active ingredients

Bevacizumab

AusPAR Date

11 March 2015

Published

1 April 2015

Submission Number

PM-2013-03227-1-4

Submission Type

Extension of indications

Decision

Approved